Kolexia
Le Louedec Félicien
Pharmacien
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France
41 Activités
275 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Sarcomes Cellules tumorales circulantes Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Néphrocarcinome Déficit en dihydropyrimidine déshydrogénase Tumeurs du rectum

Industries

Sandoz
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
British journal of cancer   25 janvier 2024
Model-informed precision dosing of high-dose IV busulfan in Thai pediatric patients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.
British journal of clinical pharmacology   20 mars 2023
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug-Drug Interaction and Improving Clinical Practice.
Clinical pharmacokinetics   11 janvier 2023
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
British journal of clinical pharmacology   03 octobre 2022
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr.
CPT: pharmacometrics & systems pharmacology   08 septembre 2021
Genetic variations of CYP450 and ABC transporters associated with trabectedin severe hepatotoxicity in patients with advanced soft-tissue sarcoma: a pharmacogenetic study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Correction to: Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
Cancer chemotherapy and pharmacology   26 mai 2021
Setting the Dose of Checkpoint Inhibitors: The Role of Clinical Pharmacology.
Clinical pharmacokinetics   26 mai 2021
VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients.
Journal of geriatric oncology   11 mars 2021